<?xml version="1.0" encoding="UTF-8"?>
<p id="Par47">Activated AlloStim
 <sup>®</sup> express high density CD40L and type 1 cytokines, including IFN-ϒ, TNF-α and GM-CSF. AlloStim
 <sup>®</sup> has been shown to modulate the immune systems of heavily pre-treated metastatic cancer patients (which resemble the senescent immune systems of the elderly) and has been used in protocols which were designed to elicit the same anti-tumor mechanism of allogeneic stem cell transplant procedures (graft vs tumor or “GVT”) without the need for a matched donor, chemotherapy conditioning or risk of GVHD [
 <xref ref-type="bibr" rid="CR30">30</xref>, 
 <xref ref-type="bibr" rid="CR31">31</xref>, 
 <xref ref-type="bibr" rid="CR34">34</xref>–
 <xref ref-type="bibr" rid="CR38">38</xref>].
</p>
